BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,179,973 | -16.0% | 31,266 | +1.4% | 0.07% | -9.2% |
| Q2 2023 | $1,404,572 | +12.4% | 30,829 | +0.0% | 0.08% | +15.2% |
| Q1 2023 | $1,249,995 | -23.0% | 30,818 | -3.2% | 0.07% | -19.5% |
| Q4 2022 | $1,623,238 | +2.2% | 31,847 | +7.9% | 0.08% | -14.6% |
| Q3 2022 | $1,589,000 | -16.4% | 29,507 | -0.3% | 0.10% | -11.9% |
| Q2 2022 | $1,901,000 | -17.6% | 29,596 | -0.6% | 0.11% | -0.9% |
| Q1 2022 | $2,307,000 | -6.4% | 29,760 | +3.7% | 0.11% | -6.8% |
| Q4 2021 | $2,464,000 | +10.2% | 28,708 | +3.3% | 0.12% | +2.6% |
| Q3 2021 | $2,236,000 | +3.7% | 27,801 | +3.8% | 0.12% | +4.5% |
| Q2 2021 | $2,156,000 | -0.1% | 26,777 | +4.7% | 0.11% | -6.0% |
| Q1 2021 | $2,158,000 | +6.6% | 25,584 | +1.4% | 0.12% | -3.3% |
| Q4 2020 | $2,025,000 | +4.4% | 25,238 | +4.7% | 0.12% | -9.7% |
| Q3 2020 | $1,939,000 | -1.8% | 24,105 | +5.1% | 0.13% | -6.9% |
| Q2 2020 | $1,975,000 | +37.6% | 22,939 | +29.8% | 0.14% | +13.4% |
| Q1 2020 | $1,435,000 | +6.1% | 17,674 | +9.3% | 0.13% | +44.3% |
| Q4 2019 | $1,352,000 | -3.0% | 16,167 | +1.5% | 0.09% | -21.4% |
| Q3 2019 | $1,394,000 | +7.9% | 15,935 | +1.0% | 0.11% | +5.7% |
| Q2 2019 | $1,292,000 | +0.8% | 15,778 | +0.0% | 0.11% | -1.9% |
| Q1 2019 | $1,282,000 | +24.7% | 15,772 | +0.9% | 0.11% | +11.3% |
| Q4 2018 | $1,028,000 | -16.6% | 15,625 | -2.3% | 0.10% | -4.0% |
| Q3 2018 | $1,233,000 | -0.2% | 15,993 | -4.4% | 0.10% | -3.8% |
| Q2 2018 | $1,236,000 | +12.0% | 16,736 | -1.4% | 0.10% | +11.7% |
| Q1 2018 | $1,104,000 | -1.4% | 16,979 | -2.0% | 0.09% | +2.2% |
| Q4 2017 | $1,120,000 | -1.9% | 17,324 | -4.8% | 0.09% | -6.1% |
| Q3 2017 | $1,142,000 | -56.2% | 18,200 | -57.7% | 0.10% | -57.9% |
| Q2 2017 | $2,608,000 | +15.1% | 43,074 | -1.4% | 0.23% | +13.7% |
| Q1 2017 | $2,265,000 | +22.6% | 43,675 | +4.8% | 0.20% | +19.2% |
| Q4 2016 | $1,848,000 | -0.9% | 41,685 | +6.4% | 0.17% | -5.0% |
| Q3 2016 | $1,864,000 | +15.2% | 39,165 | +9.4% | 0.18% | +11.0% |
| Q2 2016 | $1,618,000 | -5.1% | 35,788 | -13.8% | 0.16% | -11.9% |
| Q1 2016 | $1,705,000 | +9.8% | 41,504 | +2.0% | 0.18% | +5.1% |
| Q4 2015 | $1,553,000 | +19.0% | 40,706 | +2.5% | 0.18% | +15.0% |
| Q3 2015 | $1,305,000 | -48.3% | 39,731 | +10.2% | 0.15% | -44.4% |
| Q2 2015 | $2,522,000 | +6.1% | 36,063 | +4.0% | 0.28% | +7.8% |
| Q1 2015 | $2,376,000 | +3.8% | 34,686 | +8.8% | 0.26% | +0.8% |
| Q3 2014 | $2,289,000 | +7.2% | 31,890 | +8.0% | 0.25% | +12.4% |
| Q2 2014 | $2,136,000 | +10.7% | 29,540 | +12.7% | 0.22% | +5.6% |
| Q1 2014 | $1,929,000 | +70.7% | 26,220 | +61.4% | 0.21% | +53.2% |
| Q4 2013 | $1,130,000 | +23.1% | 16,242 | +16.2% | 0.14% | +15.8% |
| Q3 2013 | $918,000 | -0.5% | 13,972 | +4.9% | 0.12% | -4.8% |
| Q2 2013 | $923,000 | – | 13,324 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |